Form 8-K - Current report:
SEC Accession No. 0001140361-21-005853
Filing Date
2021-02-23
Accepted
2021-02-23 17:00:33
Documents
13
Period of Report
2021-02-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT brhc10020673_8k.htm   iXBRL 8-K 32310
  Complete submission text file 0001140361-21-005853.txt   222105

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmy-20210219.xsd EX-101.SCH 5017
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20210219_def.xml EX-101.DEF 18572
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20210219_lab.xml EX-101.LAB 28668
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20210219_pre.xml EX-101.PRE 20872
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10020673_8k_htm.xml XML 8448
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 21666537
SIC: 2834 Pharmaceutical Preparations